6160 completed, 644 terminated, 585 recruiting, 412 unknown. 8495 Phase 1, 1662 Phase 2.
Follow Placebo: new trials by email Literature Review of Placebo trials Research Report on Placebo
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety Study of CZ10 in Healthy Volunteers Contrast Media, Placebo - Healthy Volunteer Study | Phase 1 | Not yet recruiting | Nextrast, Inc. | 24 | 2050-01-01 | 2024-11-29 |
| FGF-1 for Intramuscular Injection for the Treatment of Peripheral Arterial Disease FGF-1, Placebo - Peripheral Arterial Disease, Stenosis | Phase 1 / Phase 2 | Not yet recruiting | Venturis Therapeutics, Inc. | 24 | 2028-10-15 | 2026-08-19 |
| Terazosin for Dementia With Lewy Bodies Terazosin Hydrochloride, Placebo - Dementia With Lewy Bodies | Phase 1 / Phase 2 | Not yet recruiting | Qiang Zhang | 40 | 2027-10-01 | 2026-03-12 |
| Behavioral Pharmacology of THC and Beta-Myrcene Placebo, THC, Beta-Myrcene - Cannabis Use | Phase 1 | Not yet recruiting | Johns Hopkins University | 32 | 2027-07-01 | 2026-07-31 |
| Pilot Studies Testing the Use of Oral Amitriptyline in Reducing Localized Burn Injury-induced Microvesicle Particle Release Amitriptyline, Placebo - Microvesicle Particles, Thermal Burn | Phase 1 | Not yet recruiting | Wright State University | 20 | 2027-06-01 | 2026-07-17 |
| A First-in-Human SAD and MAD Study in Healthy Participants to Evaluate Oral YR011 Tablet Kv1.3 potassium channel blocker (PA032, investigational oral small-molecule drug), Placebo - Safety, Tolerability | Phase 1 | Not yet recruiting | Hangzhou Yirui Pharmaceutical Technology Co., Ltd | 64 | 2027-04-01 | 2026-07-30 |
| A Clinical Trial of Iron Supplementation for Youth With ADHD and Restless Sleep Ferrous Sulfate, Placebo - ADHD, Sleep Problems | Phase 1 / Phase 2 | Not yet recruiting | Hugo W. Moser Research Institute at Kennedy Krieger, Inc. | 70 | 2027-03-01 | 2026-05-04 |
| LMT503 First-in-human SAD, MAD, and FE Study LMT503, Placebo - Inflammatory Bowel Disease, Colitis, Ulcerative | Phase 1 | Not yet recruiting | Lmito Therapeutics Inc. | 72 | 2027-03-01 | 2026-09-01 |
| Microbiome Intervention for CAR-T Optimization and Response (MICRO-CART) Live Biotherapeutic Product (LBP), Placebo - Lymphoma, B-Cell, Multiple Myeloma | Phase 1 | Not yet recruiting | University of Chicago | 32 | 2027-02-23 | 2026-10-22 |
| Study to Assess Drug Levels, Immune Response, Safety and Tolerability of BMS-986446 in Healthy Chinese Participants. BMS-986446, Placebo - Healthy Volunteers | Phase 1 | Not yet recruiting | Bristol-Myers Squibb | 10 | 2027-02-10 | 2026-10-01 |
| A Study of Single Ascending Doses of NI112 in Adults With Amyotrophic Lateral Sclerosis (ALS) NI112, Placebo - Amyotrophic Lateral Sclerosis (ALS) | Phase 1 | Not yet recruiting | Sachi Bioworks Inc. | 40 | 2027-01-22 | 2026-10-30 |
| Preliminary Evaluation of the Safety and Tolerability of SPOT-mRNA01 Subcutaneously Administered in Healthy Subjects SPOT-mRNA01, Placebo - Skin Aging | Phase 1 | Not yet recruiting | SIPO Biotechnology Co. Ltd. | 10 | 2027-01-11 | 2026-04-23 |
| A Study Testing the Safety and Possible Benefits of an Ear Injection of a New Compound, Paliroden, in People With Type 2 Diabetes Who Have Difficulty Understanding Speech in Noisy Situations CIL001 (Paliroden), Placebo - Cochlear Synaptopathy | Phase 1 / Phase 2 | Not yet recruiting | Cilcare SAS | 135 | 2027-01-01 | 2026-10-26 |
| A Study to Learn About How Safe Nitroglycerin is and How it Affects the Body When Taken Along With Nurandociguat in People With Coronary Artery Disease Nitroglycerin spray, Nurandociguat, Placebo - Stable Coronary Artery Disease | Phase 1 | Not yet recruiting | Bayer | 36 | 2027-01-01 | 2026-10-06 |
| A Study Testing Safety and Efficacy of Transtympanic Paliroden for the Treatment of Cochlear Synaptopathy in Participants With Chronic, Constant Tinnitus paliroden (CIL001), Placebo - Tinnitus, Bilateral, Cochlear Synaptopathy | Phase 1 / Phase 2 | Not yet recruiting | Cilcare SAS | 60 | 2027-01-01 | 2026-09-17 |
| Relaxin Therapy for Atrial Fibrillation Relaxin, Placebo - Atrial Fibrillation (AF), Arrhythmia | Phase 1 / Phase 2 | Not yet recruiting | Deeptankar DeMazumder | 208 | 2027-01-01 | 2026-01-22 |
| Impact of BPC-157 on Recovery Following Rotator Cuff Repair Surgery BPC-157, Sham (No Treatment) - Rotator Cuff Tear | Phase 1 | Not yet recruiting | University of Arkansas | 30 | 2027-01-01 | 2026-09-03 |
| A First-in-Human SAD and MAD Study in HV to Evaluate Oral YR011 Tablet Kv1.3 potassium channel blocker (PA032, investigational oral small-molecule drug), Placebo - Safety, Tolerability | Phase 1 | Not yet recruiting | Hangzhou Yirui Pharmaceutical Technology Co., Ltd | 64 | 2027-01-01 | 2026-10-16 |
| Safety and Immunogenicity of VPM1002 Vaccination or BCG Revaccination Against TB in Pre-Adolescents Living With and Without HIV in South Africa VPM1002 Vaccine, BCG Vaccine, Placebo - Tuberculosis, HIV Infections | Phase 1 / Phase 2 | Withdrawn | International Maternal Pediatric Adolescent AIDS Clinical Trials Group | 2026-12-31 | 2026-08-17 | |
| Phase 1 Trial to Evaluate Safety and Immunogenicity of MVA-BN-EBV in Healthy Young Adults MVA-BN-EBV, Placebo - Epstein Barr Virus (EBV) Infection | Phase 1 | Not yet recruiting | Bavarian Nordic | 15 | 2026-12-15 | 2026-10-22 |
Showing 20 of 8495. Sign in to see all of them.
Diabetes Mellitus, Type 2 (333) · Obesity (245) · Alzheimer Disease (191) · COVID-19 (181) · Diabetes Mellitus (157) · Asthma (121) · Overweight (120) · Schizophrenia (111) · Arthritis, Rheumatoid (109) · Parkinson Disease (108) · Influenza, Human (100) · Pulmonary Disease, Chronic Obstructive (95) · Pain (91) · HIV Infections (83) · Dermatitis, Atopic (79)
Pfizer (265) · Boehringer Ingelheim (261) · Eli Lilly and Company (256) · GlaxoSmithKline (256) · AstraZeneca (241) · National Institute of Allergy and Infectious Diseases (NIAID) (167) · Novo Nordisk A/S (142) · Merck Sharp & Dohme LLC (112) · Hoffmann-La Roche (100) · Bristol-Myers Squibb (85) · Janssen Research & Development, LLC (79) · Amgen (74) · Biogen (59) · Novartis Pharmaceuticals (59) · Yale University (55)
United States (3733) · United Kingdom (749) · China (725) · Germany (545) · Australia (517) · Canada (322) · Netherlands (300) · Belgium (296) · Japan (294) · Spain (190) · South Korea (178) · France (175) · New Zealand (141) · Sweden (106) · Poland (98)
PMID 34473343, PMID 29912955, PMID 40680102, PMID 41388232, PMID 20844485, PMID 22700038, PMID 24408516, PMID 27568215, PMID 28647166, PMID 30677788, PMID 33331662, PMID 36690550, PMID 37983082, PMID 40190112, PMID 24184147, PMID 25749867, PMID 26432909, PMID 29480210, PMID 29856004, PMID 30908082, PMID 30957581, PMID 31314925, PMID 33595690, PMID 35713300, PMID 36045513, PMID 36147329, PMID 36451029, PMID 38780109, PMID 40185989, PMID 42684025, PMID 11927799, PMID 12119802, PMID 15738343, PMID 20175977, PMID 20629533, PMID 20926833, PMID 22426327, PMID 22435370, PMID 22726593, PMID 22914365, PMID 25185797, PMID 25296098, PMID 25387217, PMID 25603819, PMID 25656305, PMID 25681059, PMID 25801652, PMID 25830322, PMID 26225223, PMID 26290435
2017 (94), 2015 (85), 2014 (81), 2018 (74), 2016 (66), 2019 (58), 2023 (54), 2009 (45), 2025 (45), 2008 (23), UL1RR024150 (10), 2004 (6), 2005 (5), P01HL076611 (5), P50DA018197 (4)